Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Antibe Therapeutics Inc(Pre-Merger) ATBPF

Antibe Therapeutics Inc. is a clinical-stage biotechnology company. The Company is leveraging its hydrogen sulfide (H2S) platform to develop therapies to target inflammation arising from a range of medical conditions. The Company’s pipeline includes assets that seek to overcome the gastrointestinal ulcers and bleeding associated with nonsteroidal anti-inflammatory drugs (NSAIDs). Its lead drug, otenaproxesul, is in clinical development as an alternative to opioids and NSAIDs for acute pain. Its second pipeline drug, ATB-352, is being developed for a specialized pain indication. The Company also focuses on inflammatory bowel disease (IBD). Otenaproxesul combines a moiety that releases hydrogen sulfide with naproxen, a non-steroidal, anti-inflammatory drug. ATB-352 is an H2S-releasing derivative of ketoprofen, a potent NSAID commonly prescribed for acute pain. Its IBD candidates are being designed to maintain the efficacy, safety, and pharmacokinetic properties of ATB-429.


GREY:ATBPF - Post by User

Comment by Stutterson Apr 25, 2022 11:14am
71 Views
Post# 34628960

RE:The creation of Stockings and Stutters (Stuffers) ...

RE:The creation of Stockings and Stutters (Stuffers) ...
MrMugsy wrote: Ever see Stutter's first post ...

--------------------

Changes in speech reveal a dishonest person Stammering, stuttering, and spee...

November 24, 2021


---------------

Let me tell you about dishonesty - Stutters was only created in late 2021 to bash ATE - has no interest in any other stock.  So ... who is he really - further hiding behind a second alias here ?

Let's just have a little honesty from you Stutters.

Even Stockings tried to be a little more open minded when he started here in April of 2021 but he's only interested in ATE as well - not following anything else.  Looks like he was buying at max and then joined the conversation as the stock was on the way down - wondering why his investment wasn't a "sure thing."  Then he needed someone to blame.  Don't think he has any stock experience either - certainly not in drug development.

Just maybe ... Stockings joined and then ... as he got more frustrated with ATE ... he created Stutters to bash a little harder.

The other possibility is ... Stockings got Stutters to buy at max price too ... told him it was a sure thing ... now they're both crying - pointing fingers wherever possible.

Come on - give credit where credit is due ... I'm really close ... aren't I ?

Hahaha ! 

 



<< Previous
Bullboard Posts
Next >>